| PERIOD ENDING | 28-Feb-09 | 29-Feb-08 | | Total Revenue |
-
|
-
| | Cost of Revenue |
-
| 1 | | | Gross Profit |
-
| (1) | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 217 | 37 | | Non Recurring | 3,081 |
-
| | Others | 20 |
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | (3,318) | (38) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| | Earnings Before Interest And Taxes | (3,318) | (38) | | Interest Expense | 302 |
-
| | Income Before Tax | (3,621) | (38) | | Income Tax Expense |
-
|
-
| | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | (3,621) | (38) | | | Non-recurring Events | | Discontinued Operations | (7) |
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (3,627) | (38) | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | ($3,627) | ($38) |
|
0.30% Nasdaq 
Income Statement
